High Svr Rates with ABT-493 + ABT-530 Co-Administered for 8 Weeks in Non-Cirrhotic Patients with HCV Genotype 3 Infection

Authors :: P. Kwo
Stanley Wang
Jens Kort
Teresa I. Ng
E.J. Gane
Simone I. Strasser
Federico J. Mensa
Sandra S. Lovell
Andrew J. Muir
David L. Wyles
Stephen D. Shafran
C.-W. Lin
Maurizio Bonacini
Source :: Journal of Hepatology. 64:S186
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: 03 medical and health sciences
medicine.medical_specialty
0302 clinical medicine
Hepatology
business.industry
030220 oncology & carcinogenesis
Internal medicine
Genotype
medicine
030211 gastroenterology & hepatology
business
Gastroenterology

Tools